Prostate Specific Antigen Antikörper (N-Term)
Kurzübersicht für Prostate Specific Antigen Antikörper (N-Term) (ABIN7598882)
Target
Alle Prostate Specific Antigen (PSA) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- N-Term
-
Verwendungszweck
- Anti-PSA (Prostate-specific antigen)
-
Spezifität
- PSA (Prostate-specific antigen)
-
Immunogen
- Peptide derived from N-terminal sequence of human PSA. Antibody recognizes the epitope between Arg77 -Gln88.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 20 mM Tris-HCI, pH 8.0, Stabilizer: 20 mg/mL BSA, Preservative: 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- +2 °C to +8 °C
-
-
- Prostate Specific Antigen (PSA)
-
Andere Bezeichnung
- PSA
-
Hintergrund
- PSA represents a prostate cancer protein marker, strongly expressed in both normal and neoplastic prostatic tissue. This protein is expressed at lower levels also in in breast tumors, endometrium, or renal cell carcinomas. Together with Prostate-Specific Acid Phosphatase (PSAP), PSA expression is detected in blood samples and/or prostate tissue-related biopsies, in order to confirm the prostatic origin of metastatic carcinoma.
-
UniProt
- P07288
-
Pathways
- Komplementsystem
Target
-